Transcription

1 Influenza A virus infection increases IgE production and airway responsiveness in aerosolized antigen-exposed mice Shunsuke Suzuki, MD, Yuzo Suzuki, MD, PhD, Naomi Yamamoto, MD, Yutaka Matsumoto, MD, PhD, Akira Shirai, MD, and Takao Okubo, MD, PhD Yokohama, Japan Background: Respiratory viral infection is known clinically to promote sensitization to antigen inhalation and the development of asthma. Objective: The purpose of this investigation was to determine whether influenza type A virus infection enhances inhalation sensitization and increases airway responsiveness in mice. Methods: Mice were infected by intranasal inoculation with influenza A viruses (strains: H 1 N 1 and H 3 N 2 ) or PBS. Animals were exposed to aerosols of ovalbumin on day 3. Two weeks after ovalbumin sensitization, mice were challenged with ovalbumin aerosols; 24 hours later, airway responsiveness (AR) to inhaled methacholine, levels of ovalbumin-specific IgE, and bronchoalveolar lavage fluid (BALF) were examined. Results: Neither influenza A virus (H 1 N 1 nor H 3 N 2 ) alone nor ovalbumin sensitization alone caused changes in AR or IgE. However, ovalbumin sensitization after inoculation with either influenza A virus increased AR and levels of ovalbumin-specific IgE. On BALF-cell analysis, ovalbumin sensitization after inoculation with influenza virus A increased the number of lymphocytes but not the number of eosinophils. No difference in AR or IgE levels was observed between the 2 strains of influenza A viruses. Immmunostaining of BALF cells showed an increase in T cells, especially CD8 + cells, with ovalbumin sensitization after inoculation with influenza virus A. Conclusion: Infection by influenza A virus enhances sensitization to inhaled antigens and airway responsiveness in mice by means of mechanisms including CD8 + cells and antigen-specific IgE. (J Allergy Clin Immunol 1998;102: ) Key words: Virus infection, influenza A virus, IgE, airway hyperresponsiveness, CD8 + cells, CD4 + cells Clinically, asthma is exacerbated by respiratory viral infections. In older children and adults, rhinovirus, coronavirus, and influenza A virus infections cause wheezing. 1-3 Airway hyperresponsiveness develops in subjects who have naturally acquired colds or who were infected with respiratory viruses transiently. 4 Acute respiratory infections have also been implicated in the pathogenesis From the First Department of Internal Medicine, Yokohama City University School of Medicine. Received for publication Aug 15, 1997; revised June 4, 1998; accepted June 17, Reprint requests: Shunsuke Suzuki, MD, First Department of Internal Medicine, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama 236, Japan. Copyright 1998 by Mosby, Inc /98 $ /1/ Abbreviations used BAL: Bronchoalveolar lavage BALF: Bronchoalveolar lavage fluid FRC: Functional residual capacity H 1 N 1 : Influenza virus A/PR/8/34 H 3 N 2 : Influenza virus A/Guizhou-X PD 35 Mch: Cumulative dose of inhaled methacholine at which airway resistance increases by 35% PFU: Plaque-forming unit sraw: Specific airway resistance sraw L : sraw of the lower airway of asthma. It is known that children with respiratory virus infection later experience wheezing, airway hyperresponsiveness, and asthma. 5,6 From epidemiologic studies of respiratory infection 7 and asthma and allergic rhinitis 8 in the same area, Smith 9 found that viral lower-respiratory infection in early life triggers the onset of asthma. Although it is still unknown how viral infection induces asthma, respiratory viral infections may contribute to the development of IgE antibodies to environmental antigens. Influenza causes exfoliation of epithelial cells and increases permeability of the respiratory mucosal barrier to antigen penetration with the enhanced likelihood of IgE antibody sensitization. Respiratory virus infection has been proposed as a common trigger factor in the development of allergy in genetically susceptible children. 10 Several studies of sensitization to allergens by inhalation alone are reported, and repeated exposure to allergen at a high concentration is needed. 11 Sakamoto et al 12 have shown that IgE antibody production in response to an inhaled antigen occurs in mice that have been infected with influenza A virus, but not in animals with no infection. Thus we hypothesized that a respiratory viral infection promotes sensitization to inhaled antigen and may cause asthma. To test this hypothesis, mice were infected with influenza type A virus; during the acute phase, animals were exposed to aerosols of ovalbumin. Two weeks after ovalbumin sensitization, mice were challenged with ovalbumin aerosols; 24 hours after challenge, airway responsiveness to methacholine, levels of ovalbumin-specific IgE, and bronchoalveolar lavage fluid were examined. We used 2 strains of influenza A viruses (A/PR/8/34 [H 1 N 1 ] and A/Guizhou-X [H 3 N 2 ]) to examine any difference in the effect of the strain of influenza A viruses on allergic sensitization.

2 J ALLERGY CLIN IMMUNOL VOLUME 102, NUMBER 5 Suzuki et al 733 METHODS Animals Six- to 11-week-old male BALB/c mice (Japan SLC, Shizuoka, Japan) were used. The animals were maintained on ovalbumin-free diets and kept under special pathogen-free conditions in a laminar flow container. Each group of animals was isolated. All experimental animals used in this study were maintained under a protocol approved by the Institutional Animal Care and Use Committee of the Yokohama City University School of Medicine. Allergen Ovalbumin (Sigma Chemical, St. Louis, Mo) was dissolved in PBS to a concentration of 0.1%. Ten milliliters of alum adjuvant (10 mg/ml) was added to 10 ml of 0.1% ovalbumin; the final concentration of ovalbumin was 0.05%. Aerosolized ovalbumin was used for sensitization and challenge. Sensitization and challenge Mice were sensitized by inhalation of aerosolized 0.05% ovalbumin or PBS with an ultrasonic nebulizer (NE-U1013; Omron, Tokyo, Japan). Aerosols of ovalbumin or PBS were exposed to animals in a plexiglass chamber (capacity, 23.5 L) for 30 minutes each day over a 5-day period. The inhalation challenge was an aerosol of 2% ovalbumin or PBS from the ultrasonic nebulizer for 30 minutes. Viruses Two mouse-adapted strains of influenza A, A/PR/8/34 (H 1 N 1 ) and A/Guizhou-X (H 3 N 2 ) (provided by Drs M. Tashiro and S. Tamura, Japan National Institute of Health, respectively), were used in the present study. The viruses were incubated in Madin-Darby canine kidney cell monolayers for 2 days, and then viruses were harvested. The virus titer was quantitated by plaque assay as described previously. 13 The titer of the pool used in the present study was plaque-forming units (PFU) in H 1 N 1 and PFU in H 3 N 2. Animals were anesthetized with diethylene ether and inoculated intranasally with 50 L of the diluted virus solution. The virus stock solutions were diluted 10-fold from 10 1 to 10 6 with PBS. Airway responsiveness Nonspecific airway responsiveness was measured by inhalation of methacholine aerosols in unanesthetized, spontaneously breathing animals. Specific airway resistance (sraw) was measured in a double plethysmograph apparatus consisting of a head chamber and chest chamber for small animals (Buxco, Troy, NY), according to the methods of Pennock et al. 14 Briefly, pressure signals from the head and chest chambers represent nasal flow and thoracic flow, respectively. These 2 signals were displayed on an oscilloscope and used to calculate total respiratory duration (T T ) and the time lag of nasal flow (δt). sraw was calculated according to the following formula: sraw = (1/ω) P B 1.36 tanθ where, ω is angular speed (= 2π [1/T T ]), P B is atmospheric pressure in millimeters of mercury, and θ is a phase angle (= 2π [δt/t T ]). The head and body chambers were warmed to 37 C before the measurement, and the air in the head chamber was saturated with water vapor by a pool of heated water at 37 C inside the box. The neck of the animal was placed through the bore of the rubber plate separating the 2 chambers and sealed tightly with clay to avoid air leak between the 2 chambers. The measurement of sraw was performed only when the animals were quiet. To examine whether sraw by the double plethysmograph represents changes in airway resistance of the lower airway, we anesthetized animals with intraperitoneal injection of pentobarbital sodium (1 mg/animal) and inserted 7-mm long sterile plastic tube into the trachea. The tube was connected to the head chamber of the body plethysmograph, so that we were able to measure sraw of the lower airway (sraw L ). Both sraw and sraw L were measured after aerosol inhalation of either PBS or methacholine 12.5 mg/ml. We compared sraw and sraw L in 5 nonsensitized and noninfected animals. The concentration of methacholine was adjusted from 12.5 mg/ml to 49 µg/ml by serial 4-fold dilutions in PBS. Aerosols from a DeVilbiss 646 nebulizer (De Vilbiss, Somerset, Pa) were delivered to the animals by mask, which was put over the face; the animals were placed in the chest chamber, and the head chamber was disconnected. The animals were exposed to aerosols for 1 minute at each concentration; then the head chamber was connected, and sraw was measured. Inhalation of methacholine was started from the concentration of 49 g/ml, and the concentration was increased until sraw increases 35% or more of the baseline value. From the methacholine-sraw curve, we calculated the cumulative dose (sum of all inhaled doses [PD 35 Mch]) at which sraw increases 35% from the baseline value after inhalation of PBS aerosols. One unit was defined as the dose inhaled at 1 mg/ml methacholine for 1 minute. When an animal s sraw did not increase more than 35% to a concentration of 12.5 mg/ml, all 5 doses from to 12.5 units were summed and PD 35 Mch was calculated to be 16.7 units. Bronchoalveolar lavage (BAL) Immediately after the assessment of airway responsiveness, the animals were anesthetized with pentobarbital sodium (40 mg/kg). PBS (0.6 ml) was instilled through the tracheal cannula and recovered by gentle manual aspiration. This lavage was repeated 4 times. The recovered fluid was immediately centrifuged (100g for 10 minutes at 4 C). The cell pellet was washed twice and resuspended in 1 ml of PBS. Cells were fixed to a slide by a cytocentrifuge at 100g (Cytobucket SC-2; Tomy Seiki, Tokyo, Japan) and stained with Diff-Quick (International Reagent, Kobe, Japan). Differential cell counts were performed by classification according to standard morphologic criteria of at least 200 cells. Lymphocytes in BAL fluid (BALF) were analyzed for the total number of lymphocytes and for expression of lymphoid surface markers with anti-mouse monoclonal antibodies specific for CD4, CD8, and CD90 (PharMingen, San Diego, Calif), as previously described. 15 Cells fixed to a slide were air dried, immersed in acetone solution cooled to 20 C for 10 minutes, and then stored at 80 C. The cells on the slide were incubated for 30 minutes in 0.3% H 2 O 2 in methanol and washed in distilled water and PBS for 5 minutes each. Incubation with primary antiserum diluted in PBS was done for 30 minutes. After being washed with PBS for 5 minutes, the cells on the slide were incubated with diluted biotinylated secondary antibody solution for 30 minutes. Then cells were treated with an avidin-peroxidase complex (Vectastain Elite ABC kit; Vector Laboratories, Burlingame, Calif). Peroxidase activity was demonstrated by incubation in diaminobenzidine. We counted cells positive for CD90, CD4, and CD8. IgE measurement Before and at the end of the experiment, blood was drawn from the postorbital vein or the heart of each animal to measure ovalbumin-specific IgE, respectively. Ovalbumin-specific IgE antibody levels were measured by ELISA as follows 16 : ELISA plates (96- well Immunolon II; Dynatech Laboratories, Alexandria, Va) were coated with 10 g/ml of ovalbumin. The plates were then blocked with PBS 1% BSA. Dilutions 1:10 of samples were incubated on these plates for 3 hours. Plates were washed and then overlaid with 1 g/ml of alkaline phosphatase-conjugated polyclonal anti-mouse IgE (PharMingen) for 3 hours and then washed. Plates were read in a microplate autoreader (Bio-Rad Laboratories, Hercules, Calif).

3 734 Suzuki et al J ALLERGY CLIN IMMUNOL NOVEMBER 1998 FIG 1. Body weight changes of mice are expressed as a percentage of the baseline value. Numbers represent dilution factors. The concentration of specific antibody bound to the plates was determined by comparison with a standard curve generated using high-titer antisera to ovalbumin. Histology The lungs were fixed by intratracheal instillation of buffered 20% formaldehyde solution. Lung sections were embedded in paraffin, sectioned, and stained with hematoxylin and eosin. Protocol Dose effects of viruses. To determine the dose of the 2 viruses (H 1 N 1 and H 3 N 2 ) required to cause moderate inflammation without apparent pneumonia, we inoculated intranasally with 50 L of the diluted virus solutions (from 10 1 to 10 6 ). Infection was verified by observing the pulmonary histology at 3, 7, or 14 days after inoculation. General locomotor activity, body weight, and survival rate were examined for 14 days. Five to 6 animals were used in each group. Effect of influenza A viruses infection on sensitization of ovalbumin. To examine the effects of influenza A virus infection on inhalation sensitization by ovalbumin, we divided the animals into 6 groups (5 animals in each group): group 1, PBS inoculation, PBS sensitization, and PBS challenge; group 2, PBS inoculation, ovalbumin sensitization, and ovalbumin challenge; group 3, H 1 N 1 inoculation, PBS sensitization, and PBS challenge; group 4, H 3 N 2 inoculation, PBS sensitization, and PBS challenge; group 5, H 1 N 1 inoculation, ovalbumin sensitization, and ovalbumin challenge; and group 6, H 3 N 2 inoculation, ovalbumin sensitization, and ovalbumin challenge. From the dose effect study, sublethal dosages were determined: PFU/mL and PFU/mL for H 1 N 1 and H 3 N 2, respectively. At first, we measured PD 35 Mch and drew blood from the postorbital vein to determine IgE. On day 1, inoculation by virus or PBS was performed intranasally. On days 4 to 8, animals FIG 2. Microphotographs of the lung tissue. A, Inoculation with PBS (control animal). B, H 1 N 1 infection at a 10 4 dilution ( PFU/mL) on day 7; mononuclear cell infiltration (arrowheads) in submucosal layer and loss of the epithelium of the airway were seen. C, H 3 N 2 infection at a 10 3 dilution ( PFU/mL) on day 7; loss of epithelial cells of the airway and mononuclear cell infiltration (arrowheads) were diffusely observed. (Original magnification 100.) were sensitized with ovalbumin or PBS for 30 minutes daily. On day 22, the mice were challenged with aerosols of 2% ovalbumin or PBS for 5 minutes. Twenty-four hours after challenge, airway responsiveness, levels of ovalbumin-specific IgE, and BALF were analyzed, and the lung was removed and fixed.

4 J ALLERGY CLIN IMMUNOL VOLUME 102, NUMBER 5 Suzuki et al 735 FIG 3. A comparison of total airway resistance (sraw) and the lower airway resistance (sraw L ). sraw and sraw L are closely correlated. Each symbol represents each individual (n = 5), and open and closed symbols express the values after inhalation of PBS and methacholine, respectively. FIG 4. Airway responsiveness to inhaled methacholine (PD 35 Mch). Influenza A virus inoculation with ovalbumin (OVA) sensitization increased PD 35 Mch (P <.01 for H 1 N 1 and H 3 N 2 ); however, virus infection alone did not change it. Open and crosshatched columns represents the baseline and postchallenge values, respectively. P <.01 compared with the baseline value. Statistical analysis All values are expressed as the mean ± SEM. Statistical comparison between groups was examined by 2-way analysis of variance with repeated measures (ANOVA), followed by a post-hoc comparison with the Newman-Keuls test. Two mean values were compared with the Wilcoxon matched pairs test. A P value less than.05 was considered significant. RESULTS Virus doses and acute phase responses The body weight of animals inoculated with H 1 N 1 at dilutions of 10 1 to 10 3 decreased with time; however, with dilutions of 10 4 and 10 6, weight increased (Fig 1). In the H 3 N 2 strain, body weight decreased with time at FIG 5. Changes in ovalbumin (OVA)-specific IgE level in serum. Influenza A virus inoculation with ovalbumin sensitization increased ovalbumin-specific IgE level in serum (P <.01 for both H 1 N 1 and H 3 N 2 ). Open and crosshatched columns represent the baseline and postchallenge values, respectively. P <.01 compared with the baseline value. dilutions 10 1 and 10 2 ; but at 10 3 to 10-5 dilutions, the weight increased. After being inoculated with H 1 N 1 virus at dilutions of 10 1 and 10 2, all animals died from day 7 to day 14, and the histologic evidence showed apparent pneumonia. At a 10 3 dilution of H 1 N 1 virus, no animal died, and some animals had pneumonia. Animals inoculated with 10 4 dilution of H 1 N 1 virus showed mononuclear-cell infiltration in both the submucosal layer and perivascular area and loss of the epithelium of the airway on day 7 (Fig 2, B); and little inflammation was observed on day 14. At dilutions of 10 5 and 10 6, no apparent inflammation was observed. No animal died at any dilutions of H 3 N 2 virus. At dilutions of 10 1 and 10 2 of H 3 N 2 virus, mononuclear cell infiltration was significant, and some animals showed pneumonia; but at a dilution of 10 3, loss of airway epithelial cells and mononuclear cell infiltration without pneumonia were observed (Fig 2, C). Animals inoculated with a 10 4 dilution of H 3 N 2 virus showed little mononuclear cell infiltration. For the sensitization study, we chose the dilutions of H 1 N 1 and H 3 N 2 to be 10 4 and 10 3 (ie, and PFU/mL, respectively. No inflammatory change was observed in the control (Fig 2, A). Airway resistance A comparison of sraw and sraw L for individual mice indicates a close correlation (r = 0.87, P <.01), although the absolute values of sraw L tended to be lower than those of sraw at high level of airway resistance (Fig 3). This means that sraw reflects approximately the response of the lower airway resistance. Airway responsiveness No difference in the baseline sraw before inhalation of methacholine was observed either before inoculation

6 J ALLERGY CLIN IMMUNOL VOLUME 102, NUMBER 5 Suzuki et al 737 FIG 8. Microphotographs after ovalbumin (OVA) challenge. A, Inoculation with PBS and ovalbumin sensitization; no inflammatory cell was observed. B, Inoculation with H 1 N 1 and ovalbumin sensitization. C, Inoculation with H 3 N 2 and ovalbumin sensitization. Infiltration of mononuclear cells (arrowheads) were observed around bronchioli and blood vessels in both B and C. (Original magnification 100.) zation (P <.01). The CD4/CD8 ratio of BAL cells decreased from 4.17 to 0.84 in virus infection alone and to 0.46 in virus infection with ovalbumin sensitization. Histologic examination Histologic examination of the lungs was performed 24 hours after ovalbumin or PBS challenge (on day 23). In the animals inoculated with either H 1 N 1 or H 3 N 2 virus followed by PBS sensitization, no inflammatory cell infiltration was found (Fig 8, A). However, in the virus-inoculated animals with ovalbumin sensitization (groups 5 and 6) mononuclear-cell infiltration was observed around bronchioli and blood vessels (Figs 8, B and C). No difference in inflammation was observed between groups 5 and 6. Eosinophil infiltration was not detected in any group. DISCUSSION We have demonstrated that infection with influenza A viruses enhances inhalation sensitization to ovalbumin and airway responsiveness to methacholine in mice. No difference in airway responsiveness, ovalbumin-specific IgE, or cells in BALF was observed between the 2 strains of influenza A virus (H 1 N 1 and H 3 N 2 ). This is the first report that in mice, influenza A virus infection boosts sensitization by inhalation of a low-concentration antigen and increases airway responsiveness. Although in animal asthma models, subcutaneous or intraperitoneal injection is a common route of antigen immunization, 17,18 our inhalation sensitization technique may reflect more appropriately the actual route of sensitization in the development of human asthma. Our study suggests that viral infection is important for triggering sensitization to aeroallergen and the onset of asthma. Influenza A virus infection Influenza A viruses are the most important of the respiratory viruses with respect to morbidity and mortality rates in the world. We used 2 strains of influenza A virus, H 1 N 1 and H 3 N 2, to examine differences in virus strain on the effects of allergen sensitization. In the present study, the highest dose of influenza viruses caused pneumonia and all animals died. With moderate doses of the viruses used for the allergen sensitization study, animals survived without pneumonia and showed infiltration of mononuclear cells into the airway wall and perivascular area 3 days after inoculation. Although in the present study, the virulence of viruses was stronger in strain H 1 N 1 than H 3 N 2, the doses of the 2 strains used for sensitization caused comparable changes in histologic condition. These changes were similar to previous studies. 19,20 Sensitization by ovalbumin was performed during the acute phase of infection, 4 to 8 days after virus inoculation. Thus virus infection damages the airway epithelium so that changes in epithelial permeability may facilitate the access of allergens from the lumen to the airway wall. Cells of BALF Inflammation of the lung tissue in both influenza A viruses reached a maximum at 7 days and almost recovered at 14 days after virus inoculation. BAL was performed 22 days after virus inoculation, and the total cell number in groups with virus infection alone did not differ from that of groups inoculated with PBS. The increased cell number in the lung during the acute phase of influenza virus infection declined to normal values between 2 and 4 weeks after inoculation. 21 The percent lymphocyte was increased in animals with virus infec-

7 738 Suzuki et al J ALLERGY CLIN IMMUNOL NOVEMBER 1998 tion. Circulating lymphocytes are reported to decrease during the acute phase of infection, and this decrease persists for 4 weeks after virus inoculation. 22 Lymphocytes may accumulate in the lung during virus infection, in association with a decrease in the circulation. In an analysis of lymphocyte subsets, the T-cell population was found to increase with virus infection alone (group 4). In T-cell subsets in virus infection alone (group 4), CD8 + T cells increased but not CD4 + T cells, although no change in either CD4 + or CD8 + T cells was observed in the groups inoculated with PBS (groups 1 and 2). The CD4/CD8 ratio of BALF lymphocytes decreased in influenza virus infection, primarily because of an increase in CD8 + T cells. These changes in T-cell subsets were similar to previous studies of virus infection During convalescence from respiratory syncytial virus infection, the circulating CD8 + T-cell number was lower in patients with wheezing than in those without wheezing; however, no difference in CD4 + T cells was seen. 24 This suggests that CD8 + T cells may accumulate in the lung of patients who wheeze. Allergen sensitization has been considered to be controlled by CD4 + T cells. In animal models of inhalation sensitization with ovalbumin, T-cell subsets in the spleen are reported to change; CD8 + T cells increase and the CD4/CD8 ratio decreases after sensitization. 25 Induction of a T H2 immune response to ovalbumin switches the virus-infected CD8 + T-cell response to IL-5 production. 26 Thus in allergen sensitization after virus infection, CD8 + T cells increase in the lung. It is likely that allergen sensitization after virus infection is controlled directly by CD8 + T cells or by cytokines produced by these CD8 + T cells. Eosinophils in groups of ovalbumin sensitization with virus infection were not increased in the lung tissue or BALF. In a BALB/c mouse model of sensitization by repeated exposure to ovalbumin, eosinophils were not observed in the airway, whereas the IgE level was increased. 16 Sensitization by intraperitoneal injection alone in mice did not increase eosinophils in either lung tissue or BALF, and eosinophil peroxidase activity did not change after ovalbumin challenge, although increased airway responsiveness was observed. 27 Thus, in terms of eosinophils, our results compare with other studies of mouse models of asthma. 16,27 In BALB/c mice, allergen inhalation seldom induces eosinophilia. IgE Production IgE production is reported to increase in mouse models of asthma. 11,16,27 Our sensitization with 0.05% ovalbumin inhalation alone did not cause a significant production of IgE. Inhalation of 0.05% ovalbumin with influenza infection produced a high level of ovalbuminspecific IgE but no difference in IgE production between H 1 N 1 and H 3 N 2 strains. Sakamoto et al 12 showed that 0.05% ovalbumin inhalation after influenza A virus infection generated ovalbumin-specific IgE measured by PCA. Therefore influenza A infection can amplify IgE production in exposure to aerosols of a low-concentration allergen, which alone cannot produce IgE. In a prospective study, 10 allergic symptoms and immunologic evidence (such as IgE RAST for specific allergens) developed in children with 2 parents with allergies. Upper respiratory infection occurred in 10 of the 11 children 1 to 2 months before the onset of allergic sensitization. Why does virus infection enhance production of specific IgE by allergen inhalation? Respiratory syncytial virus infected mice developed high ovalbumin-specific IgE in response to intranasal sensitization of ovalbumin; however, uninfected animals did not, suggesting that respiratory virus infection may change the immune response to antigens. 28 In rats from which alveolar macrophages were eliminated, IgE production increased in response to inhaled allergen. 29 Resident alveolar macrophages are reported to downregulate antigen that had cell functions of pulmonary dendritic cells. 30 Our BALF analysis showed that infection with influenza A viruses increased lymphocytes and decreased the number of alveolar macrophages. It is likely that virus infection enhances antigen cell function, resulting in an increase in IgE production. Further, CD8 + T cells of influenza virus infected mice can coexpress different combinations of T H1 and T H2 cytokines, IL-5, and IFN-γ.21 It is also reported that virus-specific CD8 + cells in the lung switch to IL-5 production. 26 IL-5 upregulates IgE synthesis. 31 Further, CD3 cells in the lung of influenza virus-infected mice express mrna for IL-4, IL-6, and granulocyte-macrophage colony stimulating factor. 21 Thus influenza virus infection may cause a cell-population change in lung tissue, a functional change of T cells, and cytokine production that is not restricted to the T-cell population, resulting in an increase of IgE production. Effects on airway responsiveness In mice, measurements of airway function are now feasible, and we measured sraw in unanesthetized animals because anesthesia affects the airway response. 32 However, it has been questioned that in the airway resistance measurement that uses whole body plethysmography while the animals breathed through the nose, sraw is dominated by the upper airway resistance. 33 Recently, Hamelmann et al 34 demonstrated that an index of airway resistance (Penh) by body plethysmography which includes both the upper and lower airway is a valid indicator of bronchoconstriction in inhalation challenge through the nose. We confirmed that sraw reflects the change in the lower airway resistance (Fig 3). However, our absolute values of airway resistance calculated by assuming a functional residual capacity (FRC) of 1 ml are approximately 6 cm H 2 O/mL/s in the baseline and higher than the previously reported values, 34,35 in which resistance was measured during mechanical ventilation after anesthesia was induced. Their methods of resistance measurement were different from ours. Their ventilation frequency and the magnitude of tidal ventilation were determined by each setting of a ventilator, and FRC was adjusted by controlling the end-expiratory pressure. Our mice breathed air spontaneously. Thus differences in method of resistance measurement, FRC, ventilation fre-

Mouse Anti-OVA IgM Antibody Assay Kit Catalog # 3017 For Research Use Only - Not Human or Therapeutic Use INTRODUCTION Ovalbumin (OVA) is a widely used antigen for inducing allergic reactions in experimental

The Skinny of the Immune System Robert Hostoffer, DO, FACOP, FAAP Associate Professor of Pediatrics Case Western Reserve University, Cleveland, Ohio Overview 1. Immune system of the skin 2. Immune Players

The role of antihistamines in upper respiratory tract infections Robert C. Welliver, MD Buffalo, N.Y. Antihistamines are commonly administered for URI, but their efficacy cannot be easily demonstrated.

Asthma A Presentation on Asthma Management and Prevention What Is Asthma? A chronic disease of the airways that may cause Wheezing Breathlessness Chest tightness Nighttime or early morning coughing Pathology

Life-long asthma and its relationship to COPD Stephen T Holgate School of Medicine University of Southampton Definitions COPD is a preventable and treatable disease with some significant extrapulmonary

CHAPTER 1 Definition and Pathology John Rees Sherman Education Centre, Guy s Hospital, London, UK OVERVIEW Asthma is an overall descriptive term but there are a number of more or less distinct phenotypes

Influenza A H1N1 (Swine Flu 2009) Hemagglutinin / HA ELISA Pair Set Catalog Number : SEK001 To achieve the best assay results, this manual must be read carefully before using this product and the assay

Neonatal Exposure to Microbial Phosphorylcholine Modulates the Development of House Dust Mite Allergy During Adult Life J. Sides SEM Preeyam Patel Mentor: Dr John Kearney 015 CAMBAC Research Day 9/18/15

Chapter 24 The Immune System The Immune System Layered defense system The skin and chemical barriers The innate and adaptive immune systems Immunity The body s ability to recognize and destroy specific

2009 H1N1 Influenza ( Swine Flu ) Hemagglutinin ELISA kit Catalog Number : SEK001 To achieve the best assay results, this manual must be read carefully before using this product and the assay is run as

Asthma Phenotypes: Distinction and Overlap Nikos Papadopoulos Allergy Dpt, 2 nd Pediatric Clinic, University of Athens Asthma as a syndrome From the Iliad to ADAM 33 and back again Bronchoconstriction,

Capillary exchange Fluid movement in capillaries Not all fluid is reclaimed at the venous end of the capillaries; that is the job of the lymphatic system Lymphatic vessels Lymphatic capillaries permeate

Have We Missed A Role For Neutrophils In Asthma? In Steroid-Refractory Asthma? Erwin W. Gelfand, MD Chairman, Department of Pediatrics National Jewish Health Professor of Pediatrics and Immunology University

he immune system is everywhere Some organs have developed strategies towards the immune system to keep it out or to put it under control Immune privileged organs: Brain Eye estis hyroid gland Humoral immunity

Mai ElMallah,MD Updates in Pediatric Pulmonary Care XII: An Interdisciplinary Program April 13, 2012 Recognize the importance of Pulmonary Function Testing in Cystic Fibrosis Be aware of different types

Evolution of asthma from childhood Carlos Nunes Center of Allergy and Immunology of Algarve, PT allergy@mail.telepac.pt Questionnaire data Symptoms occurring once or several times at follow-up (wheeze,

BRONCHITIS DEFINITION Bronchitis is an inflammation of the bronchial tubes (or bronchi), which are the air passages that extend from the trachea into the small airways and alveoli. Triggers may be infectious

The Immune System: Innate and Adaptive Body Defenses Outline PART 1: INNATE DEFENSES 21.1 Surface barriers act as the first line of defense to keep invaders out of the body (pp. 772 773; Fig. 21.1; Table

ParActin For Cold & Flu Colds and flu can reach epidemic proportions during the winter months. There are more than 95 million flu cases in the U.S. annually, according to the Centers for Disease Control,

REPORTS Aligning Patient Care and Asthma Treatment Guidelines Eric Cannon, PharmD Abstract This article describes how the National Asthma Education and Prevention Program Guidelines for the Diagnosis and

Line of Business: All Lines of Business Effective Date: August 16, 2017 Xolair (Omalizumab) Drug Prior Authorization Protocol (Medical Benefit & Part B Benefit) This policy has been developed through review

Explain the laboratory diagnosis of Rabies? The standard test for rabies testing is dfa. This test has been thoroughly evaluated for more than 40 years, and is recognized as the most rapid and reliable

colorimetric sandwich ELISA kit datasheet For the quantitative detection of rat TNF-alpha concentrations in cell culture supernatants. general information Catalogue Number Product Name Species cross-reactivity

( Genentech, Inc., Novartis Pharmaceuticals Corp.) September 2003 Indication The FDA recently approved Omalizumab on June 20, 2003 for adults and adolescents (12 years of age and above) with moderate to

Allergy, Asthma and the Athlete Sergio Bonini Professor of Medicine Second University of Naples Institute of Translational Pharmacology Italian National Research,Rome se.bonini@gmail.com Cancun December

H5N1 ( Avian Flu ) Hemagglutinin ELISA Pair Set Catalog Number : SEK002 To achieve the best assay results, this manual must be read carefully before using this product and the assay is run as summarized

MCMP422 Immunology and Biologics Immunology is important personally and professionally! Learn the language - use the glossary and index RNR - Reading, Note taking, Reviewing All materials in Chapters 1-3

The Immune System Biological mechanisms that defend an organism must be 1. triggered by a stimulus upon injury or pathogen attack 2. able to counteract the injury or invasion 3. able to recognise foreign

Influenza A H1N1 HA ELISA Pair Set for H1N1 ( A/Puerto Rico/8/1934 ) HA Catalog Number : SEK11684 To achieve the best assay results, this manual must be read carefully before using this product and the